3D InSight™ | 3D In Vitro Liver Disease
Imagine the complex nature of liver disease biology condensed into a few plates of assay-ready 3D microtissues. InSphero's 3D in vitro liver disease platform provides you with data and insights that exponentially accelerate your research in MASH (NASH) and MASLD (NAFLD) drug discovery.
Industry-ready 3D In Vitro Liver Disease Solutions
Benefit from our market-leading 3D in vitro human models for liver disease drug discovery. Our controlled, scalable, biologically relevant, and cost-effective screening platform for MASH and MASLD unlocks the full potential of your research.
The 3D InSight™ Human Liver Microtissues facilitate studies of disease mechanisms, enable early assessment of drug safety and efficacy, and accurately simulate human liver pathology. InSphero's 3D in vitro liver disease platform:
- Enhances your ability to predict human responses
- Reduces the chances of late-stage clinical failures
- Expedites the drug discovery process
- Preserves valuable resources for your team
Why 3D In Vitro Liver Disease with InSphero?
InSphero’s 3D In Vitro Liver Disease Platform reflects the needs of liver drug discovery researchers: high physiological relevance, uniformity, scalability, which bring your MASH and MASLD research to the next level.
Based on the 3D in vitro human liver gold standard
Unique pairs of diseased and healthy 3D microtissues
Scalable & automation-friendly 3D in vitro liver disease platform
Our Approach to 3D In Vitro Liver Disease
In-depth requirement analysis
Our expert team has supported hundreds of research groups in 3D cell culture. We invest efforts to understand your goals and requirements, so we can deliver fast and high-quality results.
Project proposal
Execution to success
